Monte Rosa Therapeutics, Inc. ($GLUE)
Filing Information
| Accession Number | 0001193125-26-085677 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 2, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
77,100
Total Value
$809,523.15
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Principal Accounting Officer | Common Stock | โ | Feb 27, 2026 | Exercise/Conversion | 25,164 | $13.41 | $337,449.24 | 47,857 | Direct | โ | View Details | |
Principal Accounting Officer | Common Stock | โ | Feb 27, 2026 | Sale | 25,164 | $18.10 | $455,506.15 | 22,693 | Direct | โ | View Details | |
Principal Accounting Officer | Common Stock | โ | Mar 2, 2026 | Exercise/Conversion | 536 | $13.41 | $7,187.76 | 23,229 | Direct | โ | View Details | |
Principal Accounting Officer | Common Stock | โ | Mar 2, 2026 | Sale | 536 | $17.50 | $9,380.00 | 22,693 | Direct | โ | View Details | |
Principal Accounting Officer | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Exercise/Conversion | 25,164 | $0.00 | $0.00 | 536 | Direct | โ | View Details | |
Principal Accounting Officer | Stock Option (Right to Buy) | Derivative | Mar 2, 2026 | Exercise/Conversion | 536 | $0.00 | $0.00 | 0 | Direct | โ | View Details |